Status:

RECRUITING

Clinical Efficacy Evaluation of a Computer-aided Colonoscopy as Compared With the Standard Colonoscopy.

Lead Sponsor:

National Taiwan University Hospital

Collaborating Sponsors:

Changhua Christian Hospital

Shin Kong Hospital

Conditions:

Colon Adenoma

Colorectal Cancer

Eligibility:

All Genders

40-80 years

Phase:

NA

Brief Summary

Colonoscopy is clinically used as the gold standard for detection of colorectal cancer (CRC) and removal of adenomatous polyps of the colon and rectum. Evidence has shown that CRC could be prevented b...

Detailed Description

This multiple-site study aims to evaluate whether a computer-aided detection (CADe) device can assist in adenoma detection rate (ADR) when compared with the current standard-of-care procedure. The sub...

Eligibility Criteria

Inclusion

  • Subjects who have given signed informed consent form
  • Informed consensus has been obtained that endoscopic resection should be performed if a lesion is found
  • Subjects who are scheduled for screening or diagnostic colonoscopy for colorectal cancer (CRC) or surveillance colonoscopy for post-polypectomy follow-up

Exclusion

  • Subjects with any of the following prior history or current conditions:
  • Contraindications to colonoscopy
  • Inflammatory bowel disease (IBD)
  • Colorectal cancer (CRC)
  • Familial adenomatous polyposis (FAP)
  • Colonic stenosis
  • Severe organ failure (cirrhosis of Child C, heart failure of ACC / AHA stage D)
  • Active gastrointestinal (GI) Bleeding
  • Pregnancy
  • Prior colorectal surgery, including colonic or rectal resection (except for appendectomy, surgery on the anus, and polypectomy)
  • Undergo colonoscopy within 3 years
  • Subjects with any of the following conditions per the investigator's judgement:
  • High suspicion of IBD, CRC, and FAP.
  • High risk of bleeding after endoscopic treatment, and difficult management of anticoagulation or antiplatelet medication.

Key Trial Info

Start Date :

March 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2025

Estimated Enrollment :

1500 Patients enrolled

Trial Details

Trial ID

NCT05240625

Start Date

March 1 2022

End Date

December 31 2025

Last Update

June 20 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

National Taiwan University Hospital

Taipei, Taiwan, 100